Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jens Bauer

Showing results (41-50 of 53) with videos related to

Pageof 6
Sort By:
Cell|January 14, 2026
EBV infection and HLA-DR15 jointly drive multiple sclerosis by myelin peptide presentationJian Wang, Yuhan Qiu, Zoe Marti, et al.
Blood|December 12, 2018
The HLA ligandome landscape of chronic myeloid leukemia delineates novel T-cell epitopes for immunotherapyTatjana Bilich, Annika Nelde, Leon Bichmann, et al.
Nature|November 23, 2021
A COVID-19 peptide vaccine for the induction of SARS-CoV-2 T cell immunityJonas S Heitmann, Tatjana Bilich, Claudia Tandler, et al.
Nature Communications|October 27, 2022
The oncogenic fusion protein DNAJB1-PRKACA can be specifically targeted by peptide-based immunotherapy in fibrolamellar hepatocellular carcinomaJens Bauer, Natalie Köhler, Yacine Maringer, et al.
Nature Communications|March 2, 2017
Spatiotemporally restricted arenavirus replication induces immune surveillance and type I interferon-dependent tumour regressionHalime Kalkavan, Piyush Sharma, Stefan Kasper, et al.
Blood Cancer Discovery|October 17, 2023
Immune Surveillance of Acute Myeloid Leukemia Is Mediated by HLA-Presented Antigens on Leukemia Progenitor CellsAnnika Nelde, Heiko Schuster, Jonas S Heitmann, et al.
The Lancet. Haematology|January 17, 2026
Personalised multipeptide-based T-cell activator for chronic lymphocytic leukaemia: an open-label, single-centre, phase 1 studyJonas S Heitmann, Yacine Maringer, Susanne Jung, et al.
Oncoimmunology|December 3, 2021
Keratinocyte differentiation antigen-specific T cells in immune checkpoint inhibitor-treated NSCLC patients are associated with improved survivalFiamma Berner, Rebekka Niederer, Jolien J Luimstra, et al.
Science Immunology|September 2, 2022
Autoreactive napsin A-specific T cells are enriched in lung tumors and inflammatory lung lesions during immune checkpoint blockadeFiamma Berner, David Bomze, Christa Lichtensteiger, et al.
Nature|May 31, 2019
Immunization expands B cells specific to HIV-1 V3 glycan in mice and macaquesAmelia Escolano, Harry B Gristick, Morgan E Abernathy, et al.
Pageof 6

Showing results (41-50 of 53) with videos related to

Sort By:
Pageof 6
Cell|January 14, 2026
EBV infection and HLA-DR15 jointly drive multiple sclerosis by myelin peptide presentationJian Wang, Yuhan Qiu, Zoe Marti, et al.
Blood|December 12, 2018
The HLA ligandome landscape of chronic myeloid leukemia delineates novel T-cell epitopes for immunotherapyTatjana Bilich, Annika Nelde, Leon Bichmann, et al.
Nature|November 23, 2021
A COVID-19 peptide vaccine for the induction of SARS-CoV-2 T cell immunityJonas S Heitmann, Tatjana Bilich, Claudia Tandler, et al.
Nature Communications|October 27, 2022
The oncogenic fusion protein DNAJB1-PRKACA can be specifically targeted by peptide-based immunotherapy in fibrolamellar hepatocellular carcinomaJens Bauer, Natalie Köhler, Yacine Maringer, et al.
Nature Communications|March 2, 2017
Spatiotemporally restricted arenavirus replication induces immune surveillance and type I interferon-dependent tumour regressionHalime Kalkavan, Piyush Sharma, Stefan Kasper, et al.
Blood Cancer Discovery|October 17, 2023
Immune Surveillance of Acute Myeloid Leukemia Is Mediated by HLA-Presented Antigens on Leukemia Progenitor CellsAnnika Nelde, Heiko Schuster, Jonas S Heitmann, et al.
The Lancet. Haematology|January 17, 2026
Personalised multipeptide-based T-cell activator for chronic lymphocytic leukaemia: an open-label, single-centre, phase 1 studyJonas S Heitmann, Yacine Maringer, Susanne Jung, et al.
Oncoimmunology|December 3, 2021
Keratinocyte differentiation antigen-specific T cells in immune checkpoint inhibitor-treated NSCLC patients are associated with improved survivalFiamma Berner, Rebekka Niederer, Jolien J Luimstra, et al.
Science Immunology|September 2, 2022
Autoreactive napsin A-specific T cells are enriched in lung tumors and inflammatory lung lesions during immune checkpoint blockadeFiamma Berner, David Bomze, Christa Lichtensteiger, et al.
Nature|May 31, 2019
Immunization expands B cells specific to HIV-1 V3 glycan in mice and macaquesAmelia Escolano, Harry B Gristick, Morgan E Abernathy, et al.
Pageof 6